Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chemokine (C-C motif) receptor 8 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, CMGC GSK | 0.0094 | 0.0028 | 0.5 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.1067 | 0.3698 | 1 |
Brugia malayi | Presenilin family protein | 0.0246 | 0.0604 | 0.0604 |
Giardia lamblia | Kinase, CMGC GSK | 0.0094 | 0.0028 | 0.5 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0246 | 0.0604 | 1 |
Echinococcus granulosus | presenilin enhancer 2 | 0.0231 | 0.0547 | 0.052 |
Echinococcus granulosus | gamma secretase subunit aph 1 | 0.2738 | 1 | 1 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0094 | 0.0028 | 0.5 |
Echinococcus multilocularis | Nicastrin | 0.012 | 0.0127 | 0.01 |
Trichomonas vaginalis | Nicastrin precursor, putative | 0.012 | 0.0127 | 0.1727 |
Loa Loa (eye worm) | gamma-secretase subunit pen-2 | 0.0231 | 0.0547 | 0.0547 |
Echinococcus multilocularis | presenilin enhancer 2 | 0.0231 | 0.0547 | 0.052 |
Brugia malayi | hypothetical protein | 0.012 | 0.0127 | 0.0127 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0094 | 0.0028 | 0.5 |
Brugia malayi | intracellular kinase | 0.0094 | 0.0028 | 0.0028 |
Echinococcus multilocularis | gamma secretase subunit aph 1 | 0.2738 | 1 | 1 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.1067 | 0.3698 | 1 |
Loa Loa (eye worm) | gamma-secretase subunit aph-1 | 0.2738 | 1 | 1 |
Schistosoma mansoni | gamma-secretase subunit aph-1 | 0.2738 | 1 | 1 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0246 | 0.0604 | 1 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0246 | 0.0604 | 1 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.0246 | 0.0604 | 0.1569 |
Schistosoma mansoni | subfamily A22A unassigned peptidase (A22 family) | 0.0246 | 0.0604 | 0.0577 |
Onchocerca volvulus | 0.0094 | 0.0028 | 0.5 | |
Brugia malayi | hypothetical protein | 0.012 | 0.0127 | 0.0127 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.0246 | 0.0604 | 0.1569 |
Trypanosoma brucei | Aph-1 protein, putative | 0.1067 | 0.3698 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0127 | 0.0127 |
Leishmania major | presenilin-like aspartic peptidase, putative,presenilin-like aspartic peptidase, clan AD, family A22A, putative | 0.0246 | 0.0604 | 1 |
Echinococcus multilocularis | Nicastrin | 0.012 | 0.0127 | 0.01 |
Trichomonas vaginalis | Nicastrin precursor, putative | 0.012 | 0.0127 | 0.1727 |
Echinococcus multilocularis | presenilin | 0.0246 | 0.0604 | 0.0577 |
Echinococcus granulosus | presenilin | 0.0246 | 0.0604 | 0.0577 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0094 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0094 | 0.0028 | 0.0028 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0094 | 0.0028 | 1 |
Brugia malayi | gamma-secretase subunit pen-2 | 0.0231 | 0.0547 | 0.0547 |
Echinococcus granulosus | Nicastrin | 0.012 | 0.0127 | 0.01 |
Schistosoma mansoni | hypothetical protein | 0.012 | 0.0127 | 0.01 |
Entamoeba histolytica | presenilin 1 peptidase, putative | 0.0246 | 0.0604 | 1 |
Trypanosoma brucei | presenilin-like aspartic peptidase, putative | 0.0246 | 0.0604 | 0.1569 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 3300 nM | Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay | ChEMBL. | 17266208 |
IC50 (functional) | > 3300 nM | Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay | ChEMBL. | 17266208 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.